Cover Image
QR Code

Raising the Bar for Clinical Cardiac Troponin Research Studies and Implementation Science.

Keywords: Editorials; biomarkers; research; troponin EN Editorials biomarkers research troponin 2225 2228 4 06/10/21 20210608 NES 210608 B Article, see p 2214 b Over the past 3 decades, cardiac troponin (cTn) I and T have evolved as the preferred biomarkers for the detection of myocardial injury and...

Full description

Published in:Circulation Vol. 143; no. 23; pp. 2225 - 2229
Main Authors: Sandoval, Yader, Jaffe, Allan S.
Format: commentary editorial tables/charts Journal Article
Published: Lippincott Williams & Wilkins 6/8/2021
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=150775956&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 150775956
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00097322
        1FV
      jtl: Circulation
      issn: 00097322
      maglogo: N
    pubinfo:
      dt: 6/8/2021
      vid: 143
      iid: 23
      pid: 433
      pub: Lippincott Williams & Wilkins
      place: Baltimore, Maryland
    artinfo:
      ui:
        150775956
        150775956
        NLM34097442
        150775956
        10.1161/CIRCULATIONAHA.121.054926
        NLM34097442
        150775956
      ppf: 2225
      ppct: 4
      formats:
      tig:
        atl: Raising the Bar for Clinical Cardiac Troponin Research Studies and Implementation Science.
      aug:
        au:
          Sandoval, Yader
          Jaffe, Allan S.
        affil: Departments of Cardiovascular Diseases (Y.S., A.S.J.), Mayo Clinic, Rochester, MN.
      sug:
        subj:
          Troponin
          Scales
      ab: Keywords: Editorials; biomarkers; research; troponin EN Editorials biomarkers research troponin 2225 2228 4 06/10/21 20210608 NES 210608 B Article, see p 2214 b Over the past 3 decades, cardiac troponin (cTn) I and T have evolved as the preferred biomarkers for the detection of myocardial injury and in the appropriate setting to support the diagnosis of acute myocardial infarction (MI).[1] Almost all of the early data in this field were derived from observational studies including multiple key secondary analyses from acute coronary syndrome trials supporting their use.[2] Over time, analytic advancements brought by high-sensitivity (hs) cTn assays enabled the reliable measurement of very low cTn concentrations that allowed the development of various MI risk stratification approaches. This is an important feature and advantage of pragmatic RCTs as compared with traditional RCTs, which generally require patient-level informed consent, reducing generalizability and the ability to recruit an all-comers population, including the more critically ill patients who need more emergent care. One such strategy is the use of a single very low measurement of hs-cTn in patients with a nonischemic ECG to identify patients unlikely to have acute MI.
      pubtype: Academic Journal
      doctype:
        commentary
        editorial
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N